K. Shao, S. Singha, X. Clemente-casares, S. Tsai, Y. Yang et al., Nanoparticle-based immunotherapy for cancer, ACS Nano, vol.9, issue.1, pp.16-30, 2015.

J. Lu, X. Liu, Y. P. Liao, F. Salazar, B. Sun et al., Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression, Nat Commun, vol.8, issue.1, p.1811, 2017.

H. He, S. Ghosh, and H. Yang, Nanomedicines for dysfunctional macrophageassociated diseases, J Control Release, vol.247, pp.106-132, 2017.

L. M. Kranz, M. Diken, H. Haas, S. Kreiter, C. Loquai et al., Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy, Nature, vol.534, issue.7607, pp.396-401, 2016.

Q. Jiao, L. Li, Q. Mu, and Q. Zhang, Immunomodulation of nanoparticles in nanomedicine applications, Biomed Res Int, p.426028, 2014.

H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami et al., Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size, Nat Nanotechnol, vol.6, issue.12, pp.815-838, 2011.

M. Ovais, M. Guo, and C. Chen, Tailoring nanomaterials for targeting tumorassociated macrophages, Adv Mater, vol.31, p.1808303, 2019.

V. Bronte, S. Brandau, S. H. Chen, M. P. Colombo, A. B. Frey et al., Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards, Nat Commun, vol.7, p.12150, 2016.

S. K. Biswas and A. Mantovani, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nat Immunol, vol.11, issue.10, pp.889-96, 2010.

A. Mantovani, F. Marchesi, A. Malesci, L. Laghi, and P. Allavena, Tumourassociated macrophages as treatment targets in oncology, Nat Rev Clin Oncol, vol.14, issue.7, pp.399-416, 2017.

V. Fleming, X. Hu, R. Weber, V. Nagibin, C. Groth et al., Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression, Front Immunol, vol.9, p.398, 2018.

E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-pouessel et al., A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Mol Cancer Ther, vol.5, issue.7, pp.1710-1732, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00358958

G. Lollo, M. Vincent, G. Ullio-gamboa, L. Lemaire, F. Franconi et al., Development of multifunctional lipid nanocapsules for the codelivery of paclitaxel and CpG-ODN in the treatment of glioblastoma, Int J Pharm, vol.495, issue.2, pp.972-80, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01392247

M. S. Sasso, G. Lollo, M. Pitorre, S. Solito, L. Pinton et al., Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy, Biomaterials, vol.96, pp.47-62, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01392469

S. Hirsjarvi, L. Sancey, S. Dufort, C. Belloche, C. Vanpouille-box et al., Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting, Int J Pharm, vol.453, issue.2, pp.594-600, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00855672

K. Gabrusiewicz, B. Rodriguez, J. Wei, Y. Hashimoto, L. M. Healy et al., Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype, JCI Insight, vol.1, issue.2, p.85841, 2016.

R. L. Bowman, F. Klemm, L. Akkari, S. M. Pyonteck, L. Sevenich et al., Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies, Cell Rep, vol.17, issue.9, pp.2445-59, 2016.

L. Pinton, E. Masetto, M. Vettore, S. Solito, S. Magri et al., The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion, J Immunother Cancer, vol.7, issue.1, p.58, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02055603

Z. Wang, C. Zhang, X. Liu, Z. Wang, L. Sun et al., Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma, Oncoimmunology, vol.5, issue.11, p.1196310, 2016.

A. S. Berghoff, B. Kiesel, G. Widhalm, D. Wilhelm, O. Rajky et al., Correlation of immune phenotype with IDH mutation in diffuse glioma, Neuro Oncol, vol.19, issue.11, pp.1460-1468, 2017.

Z. Chen and D. Hambardzumyan, Immune Microenvironment in Glioblastoma Subtypes, Front Immunol, vol.9, p.1004, 2018.

B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, and J. P. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharm Res, vol.19, issue.6, pp.875-80, 2002.

L. Roux, G. Moche, H. Nieto, A. Benoit, J. P. Nesslany et al., Cytotoxicity and genotoxicity of lipid nanocapsules, Toxicol In Vitro, vol.41, pp.189-99, 2017.

?. Fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year

, Ready to submit your research ? Choose BMC and benefit from

S. V. Vinogradov, T. K. Bronich, and A. V. Kabanov, Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells, Adv Drug Deliv Rev, vol.54, issue.1, pp.135-182, 2002.

C. He, Y. Hu, L. Yin, C. Tang, and C. Yin, Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles, Biomaterials, vol.31, issue.13, pp.3657-66, 2010.

M. D. Dunning, A. Lakatos, L. Loizou, M. Kettunen, C. Ffrench-constant et al., Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS, J Neurosci, vol.24, issue.44, pp.9799-810, 2004.

N. Araki, T. Hatae, A. Furukawa, and J. A. Swanson, Phosphoinositide-3-kinaseindependent contractile activities associated with Fcgamma-receptormediated phagocytosis and macropinocytosis in macrophages, J Cell Sci, vol.116, issue.2, pp.247-57, 2003.

N. Araki, M. T. Johnson, and J. A. Swanson, A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages, J Cell Biol, vol.135, issue.5, pp.1249-60, 1996.

R. Lopez-iglesias, C. Peiro, S. Bellido, D. Palacin, M. Zorzano et al., Lipid rafts are required for GLUT4 internalization in adipose cells, Proc Natl Acad Sci, vol.98, issue.21, pp.12050-12055, 2001.

N. Hilf, S. Kuttruff-coqui, K. Frenzel, V. Bukur, S. Stevanovic et al., Actively personalized vaccination trial for newly diagnosed glioblastoma, Nature, vol.565, issue.7738, pp.240-245, 2019.

D. B. Keskin, A. J. Anandappa, J. Sun, I. Tirosh, N. D. Mathewson et al., Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial, Nature, vol.565, issue.7738, pp.234-243, 2019.

H. Liu, J. Mai, J. Shen, W. J. Li, Z. Zhang et al., A Novel DNA Aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells, Theranostics, vol.8, issue.1, pp.31-44, 2018.

M. Kong, J. Tang, Q. Qiao, T. Wu, Y. Qi et al., Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing Antitumor efficiency, Theranostics, vol.7, issue.13, pp.3276-92, 2017.

C. Wu, M. E. Muroski, J. Miska, C. Lee-chang, Y. Shen et al., Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment, Nanomedicine, vol.16, pp.126-163, 2019.

A. M. Ledo, M. S. Sasso, V. Bronte, I. Marigo, B. J. Boyd et al., Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells, J Control Release, vol.295, pp.60-73, 2019.

G. Lollo, K. Matha, M. Bocchiardo, J. Bejaud, I. Marigo et al., Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules, J Drug Target, vol.27, issue.5-6, pp.634-679, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02055594

C. Vanpouille-box, F. Lacoeuille, C. Belloche, N. Lepareur, L. Lemaire et al., Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules, Biomaterials, vol.32, issue.28, pp.6781-90, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00638699

D. Alizadeh, L. Zhang, J. Hwang, T. Schluep, and B. Badie, Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas, Nanomedicine, vol.6, issue.2, pp.382-90, 2010.

S. Roesch, C. Rapp, S. Dettling, and C. Herold-mende, When immune cells turn bad-tumor-associated microglia/Macrophages in glioma, Int J Mol Sci, vol.19, issue.2, p.436, 2018.

T. G. Dacoba, A. Olivera, D. Torres, J. Crecente-campo, and M. J. Alonso, Modulating the immune system through nanotechnology, Semin Immunol, vol.34, pp.78-102, 2017.

E. Blanco, H. Shen, and M. Ferrari, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat Biotechnol, vol.33, issue.9, pp.941-51, 2015.

E. K. Nduom, A. Bouras, M. Kaluzova, and C. G. Hadjipanayis, Nanotechnology applications for glioblastoma, Neurosurg Clin N Am, vol.23, issue.3, pp.439-488, 2012.

S. Mandruzzato, S. Solito, E. Falisi, S. Francescato, V. Chiarion-sileni et al., IL4Ralpha + myeloid-derived suppressor cell expansion in cancer patients, J Immunol, vol.182, issue.10, pp.6562-6570, 2009.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations